TG Therapeutics, Inc.
TGTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $28,187 | $5,060 | $23,331 |
| Dep. & Amort. | – | $59 | $56 | $62 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $16,361 | $14,972 | $11,948 |
| Change in WC | – | -$36,741 | -$48,541 | -$60,740 |
| Other Non-Cash | – | -$430 | -$262 | -$242 |
| Operating Cash Flow | – | $7,436 | -$28,715 | -$25,641 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$42 | -$25 | -$21 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | -$53,300 | -$93,309 | -$57,891 |
| Inv. Sales/Matur. | – | $49,350 | $80,400 | $73,700 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$3,992 | -$12,934 | $15,788 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | -$6,875 | -$6,123 | -$6,611 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $432 | $21 | $539 |
| Financing Cash Flow | – | -$6,443 | -$6,102 | -$6,072 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | -$2,999 | -$47,751 | -$15,925 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $133,441 | $181,192 | $197,117 |
| End Cash | – | $130,442 | $133,441 | $181,192 |
| Free Cash Flow | – | $7,394 | -$28,740 | -$25,662 |